STAT
SEPTEMBER 5, 2023
The recently approved RSV vaccines have been celebrated as key public health tools, but some vaccine experts have lamented one aspect of the trials that led to their approval — namely, that older adults were largely left out of them. People who are immunocompromised and those who live in nursing homes were also not included.
STAT
MAY 23, 2023
WASHINGTON — The incarcerated people at Federal Medical Center Devens should have been some of the first to receive the Covid vaccines, back when they first came out in December 2020. At the time, the country was prioritizing high-risk people in high-risk settings, like older Americans in nursing homes.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
STAT
SEPTEMBER 6, 2023
The recently approved RSV vaccines have been celebrated as key public health tools, but some vaccine experts have lamented one aspect of the clinical trials that led to their approval — namely, that older adults were largely left out of them , STAT tells us. Among Continue to STAT+ to read the full story…
Pharmacy Times
JANUARY 3, 2024
The study highlights the ongoing need for health care providers to recommend respiratory illness vaccinations to increase protection among nursing home residents during the peak season of infection.
NY Times
JANUARY 21, 2021
A monoclonal antibody protected residents and staff members in facilities where the virus had appeared.
NY Times
JANUARY 21, 2021
A monoclonal antibody protected residents and staff members in facilities where the virus had appeared.
pharmaphorum
AUGUST 3, 2020
While the world waits an effective coronavirus vaccine, Eli Lilly has started late-stage human testing an antibody drug as an alternative way to prevent viral transmission in high-risk locations. The post Lilly’s antibody for COVID-19 protection starts nursing home trial appeared first on.
Expert insights. Personalized for you.
342 
Let's personalize your content